AndyIChenMD

PubMed

• 1 citations
  A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.
  Titas Banerjee, Matthew Newman, Andy Chen, Richard T Maziarz, Levanto Schachter, Stephen E Spurgeon, Anusha Vallurupalli> ;Leukemia & Lymphoma. 2023 Jun 7
• 2 citations
  A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation.
  Joseph S Bubalo, Jennifer L Radke, Kenneth G Bensch, Andy I Chen, Shikha Misra, Richard T Maziarz> ;Journal of Oncology Pharmacy Practice. 2024 Mar 1
• 26 citations
  Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
  Jordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, Joshua A Hill, Vicky Wu, Aisling Cearley, Paula Perkins, Angela Kirk, Mazyar Shadman, Victor A Chow, Ajay K Gopa...> ;Blood. 2022 Jun 30
• 25 citations
  Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
  G Ghilardi, E A Chong, J Svoboda, P Wohlfarth, S D Nasta, S Williamson, J D Landsburg, J N Gerson, S K Barta, R Pajarillo, J Myers, A I Chen, L Schachter, R Yelton, H ...> ;Annals of Oncology. 2022 Sep 1
• A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma.
  Myung Sun Kim, Titas Banerjee, Andy Chen, Alexey Danilov, Renee MacKinnon, Bria Thurlow, Sujata Thakurta, Kirsten Orand, Catherine Degnin, Byung Park, Stephen E Spurgeon> ;Leukemia & Lymphoma. 2023 Mar 1
• 1 citations
  Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.
  Tycel Phillips, Mark Brunvand, Andy I. Chen, James Essell, Annalisa Chiappella, Catherine Diefenbach, Ji Cheng, David Ramies, Jamie Hirata, Franck Morschhauser, Ian W....> ;American Journal of Hematology. 2021 Nov 3
• 39 citations
  Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
  Michael Scordo, Trent P Wang, Kwang Woo Ahn, Yue Chen, Sairah Ahmed, Farrukh T. Awan, Amer Beitinjaneh, Andy I. Chen, Victor A. Chow, Bhagirathbhai Dholaria, Narendran...> ;JAMA Oncology. 2021 Jul 1
• 32 citations
  Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies
  Sarah J. Nagle, Catherine R. Murphree, Philipp W. Raess, Levanto Schachter, Andy I. Chen, Brandon Hayes-Lattin, Eneida R. Nemecek, Richard T. Maziarz> ;American Journal of Hematology. 2021 Apr 1
• Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience.
  Derek Galligan, Staci Williamson, Jessie Myers, Rebecca Silbermann, Eva Medvedova, Sarah J. Nagle, Levanto Schachter, Andy I. Chen, Emma C. Scott, Richard T. Maziarz> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Nov 5
• 82 citations
  Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b...
  Hervé Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy I. Chen, Kathryn S. Kolibaba, Dan Lu, Mark Yan,...> ;The Lancet. Oncology. 2019 Jul 1
• 155 citations
  Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (...
  Franck Morschhauser, Ian W. Flinn, Ranjana H. Advani, Laurie H. Sehn, Catherine Diefenbach, Kathryn S. Kolibaba, Oliver W. Press, Gilles Salles, Hervé Tilly, Andy I. C...> ;The Lancet. Haematology. 2019 May 1
• 3 citations
  Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/on...
  John C. Byrd, Stephen C. Smith, Nina D. Wagner-Johnston, Jeff P. Sharman, Andy I. Chen, Ranjana H. Advani, Bradley Augustson, Paula Marlton, S. Renee Commerford, Kwame...> ;Oncotarget. 2019 Jan 1
• 137 citations
  Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse
  Craig H. Moskowitz, Jan Walewski, Auayporn Nademanee, Tamás Masszi, Edward Agura, Jerzy Holowiecki, Muneer H. Abidi, Andy I. Chen, Patrick J. Stiff, Simonetta Viviani,...> ;Blood. 2018 Dec 20
• 95 citations
  Transcriptomic landscape of the blastema niche in regenerating adult axolotl limbs at single-cell resolution
  Nicholas D. Leigh, Garrett S. Dunlap, Kimberly Johnson, Rachelle Mariano, Rachel Oshiro, Alan Y. Wong, Donald M. Bryant, Bess M. Miller, Alex Ratner, A. W. Chen, Willi...> ;Nature Communications. 2018 Dec 4
• 17 citations
  Colorectal Lymphoma: A Review.
  Andy I. Chen, Craig Okada> ;Clinics in Colon and Rectal Surgery. 2018 Sep 1
• 18 citations
  Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
  Andy I. Chen, Jessica Leonard, Craig Okada, Kari Chansky, Guang Fan, Jennifer Dunlap, Philipp W. Raess, Rita M. Braziel, Alex Stentz, Richard T. Maziarz> ;Leukemia & Lymphoma. 2018 Aug 3
• 49 citations
  Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
  Sonali M. Smith, James Godfrey, Kwang Woo Ahn, Alyssa DiGilio, Sairah Ahmed, Vaibhav Agrawal, Veronika Bachanova, Ulrike Bacher, Asad Bashey, Javier Bolaños-Meade, Mit...> ;Cancer. 2018 Jun 15
• 24 citations
  Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
  Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen,...> ;Blood Advances. 2018 Apr 24
• 26 citations
  First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.
  John C Byrd, Stephen Smith, Nina Wagner-Johnston, Jeff Sharman, Andy I Chen, Ranjana Advani, Bradley Augustson, Paula Marlton, S Renee Commerford, Kwame Okrah, Lichuan...> ;Oncotarget. 2018 Feb 27
• 1 citations
  Acute promyelocytic leukemia presenting with features of metastatic osseous disease.
  Carmen Winters, Andy I. Chen, Stephen Moore, Elie Traer, Jennifer Dunlap> ;Leukemia Research Reports. 2018 Feb 12
• 84 citations
  Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Rese...
  Carla Casulo, Jonathan W. Friedberg, Kwang Woo Ahn, Christopher R. Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David J. Inwards, Mahmoud Aljurf, Andy I. Ch...> ;Biology of Blood and Marrow Transplantation. 2018 Jun 1
• 3 citations
  Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab.
  Craig Okada, Andy I. Chen, Emma C. Scott> ;Therapeutic Advances in Hematology. 2017 Mar 28
• 24 citations
  Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lym...
  Scott D. Ramsey, Auayporn Nademanee, Tamas Masszi, Jerzy Holowiecki, Muneer H. Abidi, Andy I. Chen, Patrick J. Stiff, Simonetta Viviani, John W. Sweetenham, John Radfo...> ;British Journal of Haematology. 2016 Dec 1
• 54 citations
  Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
  Ranjana H. Advani, Daniel Lebovic, Andy I. Chen, Mark Brunvand, Andre Goy, Julie E. Chang, Ephraim P. Hochberg, Sreeni Yalamanchili, Robert Kahn, Dan Lu, Priya Agarwal...> ;Clinical Cancer Research. 2017 Mar 1
• 17 citations
  Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Mul...
  Christopher R. Flowers, Luciano J. Costa, Marcelo C. Pasquini, Jennifer Le-Rademacher, Michael Lill, Tsiporah B. Shore, William P. Vaughan, Michael Craig, Cesar O. Fre...> ;Biology of Blood and Marrow Transplantation. 2016 Jul 1
• Join now to see all